Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    21449784 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED)
Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir (SCH 503034);   Biological: Pegylated interferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908);   Drug: Boceprevir placebo
2 Unknown  Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
Conditions: Hepatitis C,;   Cirrhosis
Interventions: Drug: Telaprevir;   Drug: Boceprevir;   Drug: Peg-IFN;   Drug: Ribavirin
3 Unknown  Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy
Condition: Hepatitis C, Chronic
Intervention: Drug: Stop trial intervention for boceprevir, PEG-IFN and RBV
4 Completed Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection
Condition: Hepatitis C Infection
Intervention:

Study has passed its completion date and status has not been verified in more than two years.